Harvard 21st Biennial Course in Urologic Oncology 2022

Registration

Welcome
Anthony D’Amico

Epidemiology and Genetics
Lorelei Mucci

Screening in 2022: Role of PSA and Novel Biomakers
Adam Kibel

Advanced in Multiparametric MRI for Diagnosis and Staging
Clare Tempany

Interpreting Prostrate Biopsy Reports
Michelle Hirsch

Expert Panel: Screening and Diagnosis
Moderator: Anthony D’Amico
Speakers: Michelle Hirsch, Adam Kibel, Lorelei Mucci and Clare Tempany

Break

Focal Ablation and Active Surveillance in Intermediate Risk Disease
Alexander Cole

Radical Prostatectomy in Intermediate Risk Disease
Quoc-Dien Trin

Hypofractionation and ADT use in Intermediate Risk Prostate Cancer
Neil Martin

MRI Guided Radiation therapy
Jonathan Leeman

Optimizing Systemic Therapy in the Management of Intermediate and High-Risk Prostate Cancer
Anthony D’Amico

Novel Approaches in the Preoperative Setting for the High-Risk Patient
Mary-Ellen Taplin

Biomarker Based Clinical Trials and Prostate Cancer
Martin Gleave

Expert Panel: Patient Selection
Moderator: Anthony D’Amico
Speakers: Alexander Cole, Martin Gleave, Jonathan Leeman, Neil Martin, Mary-Ellen Taplin, Quoc-Dien Trinh

Lunch

PET Imaging in the PSA Recurrent Setting-Diagnostics
Heather Jacene

Treatment of Oligo Metastatic Disease, Integration of Surgery
Speaker: Martin Gleave

Treatment of Oligo Metastatic Disease, Integration of Radiation
Paul Nguyen

Precision Medicine in Prostate Cancer
Himisha Beltran

Expert Panel: Updates in Diagnostics and Special Populations
Moderator: Adam Kibel
Speakers: Himisha Beltran, Martin Gleave, Heather Jacene and Paul Nguyen

Break

Adjuvant versus Salvage Radiation
Anthony D’Amico

Management of the Rising PSA in the Patient with M0 Castrate Sensitive Prostate Cancer
Charles Ryan

Management of Advanced Prostate Cancer in the Elderly
Alicia Morgans

Survivorship and Side effects of ADT
Phil Saylor

Management of Side Effects of Radical Prostatectomy in the Denovo and Recurrent Settings
Peter Chang

Management of Side Effects of Radiation Therapy in the Denovo and Recurrent Settings
Daniel Schmidt

Management of the Side Effects of Non-ADT Systemic Treatment for Prostate Cancer
Mark Pomerantz

Expert Panel: Management of Treatment Related Toxicity and Recurrent Disease
Moderator: Adam Kibel
Speakers: Peter Chang, Anthony D’Amico, Alicia Morgans, Mark Pomerantz, Charles Ryan, Phil Saylor and Daniel Schmidt

Management of the Rising PSA in the Patient with M0 Castrate Resistant Prostate Cancer
Atish Choudhury

Personalizing Treatment Selection in Metastatic, Hormone-sensitive Prostate Cancer
Christopher Sweeney

Immunotherapy for Prostate Cancer
Xiao Wei

Novel Androgen Receptor Targeted therapy of Castrate Resistant M1 PC

PET Imaging in the PSA Recurrent Setting – Therapeutics
Praful Ravi

Expert Panel: Management of Metastatic Prostate Cancer
Moderator: Glenn Bubley
Speakers: Atish Choudhury, Praful Ravi, Charles Ryan, Christopher Sweeney, and Xiao Wei

Break

Special Lecture, Kidney Development and Wilms Tumor: Prospects for Regeneration
George Daley

Role of Biomarkers in Diagnosis and Follow-up
Adam Feldman

Management of Superficial Bladder Cancer
Angela Smith

Genomics and its Role in the Management of Bladder Cancer
Joaquim Bellmunt

Management of Upper Tract Disease
Matthew Mossanen

Urinary Diversion after Cystectomy, Choices and Outcomes
Andrew Wagner

Lymph Node Dissection and Approaches to Radical Cystectomy
Mark Preston

Lunch

Judah Folkman Lecture: Emerging Strategies in the Fight Against Covid-19
Lindsey Baden

Genomic Predictors of Response to Chemotherapy
Kent Mouw

Personalizing Bladder Cancer Treatment in Variant Histology
Angela Smith

Neoadjuvant and Adjuvant Chemotherapy
Richard Lee

Bladder Sparing Approaches
Jason Efstathiou

Chemo and Immunotherapy for Advanced Urothelial Cancer
Joaquim Bellmunt

Expert Panel: Bladder Cancer
Moderator: Adam Kibel
Speakers: Joaquim Bellmunt, Jason Efstathiou, Adam Feldman, Richard Lee,  Kent Mouw, Matthew Mossanen, Mark Preston, Angela Smith and Andrew Wagner

Break

Management of Seminoma
Alok Tewari

Management of Stage I non-seminoma
Timothy Clinton

Updates in Radiation Therapy in Testis Cancer
Sophia Kamran

Management of Advanced Disease-Chemotherapy
Christopher Sweeney

Emerging Role of Genomics in Testis Cancer
Eliezer Van Allen

Expert Panel: Testis Cancer
Moderator: Jerome Richie
Speakers: Timothy Clinton, Sophia Kamran, Christopher Sweeney, Alok Tewari and Eliezer Van Allen

Tackling Tumor Metabolism in Renal Cell Carcinoma
Kimryn Rathmell

Updated in the Pathology Classification of Renal Cell Cancer
Michelle Hirsch

Role of Observation and Ablation for Small Renal Mass
Aria Olumi

Radical or Partial Nephrectomy: Techniques and Innovations
Steven Chang

Managing the Primary when Metastatic and Metastatectomy
Keyan Salari

Adjuvant Strategies in RCC
Toni Choueiri

Break

Advanced Disease: First Line Options
Vincent Xu

Advanced Disease: Post IO Setting
David McDermott

Non Clear Cell RCC
Bradley McGregor

Novel Targets Beyond Targeted Agents and IO Drugs
Xin Gao

Expert Panel: Renal Cell Carcinoma
Moderator: Tonu Choueiri
Speakers: Steven Chang, Xin Gao, Michelle Hirsch, David McDermott, Bradley McGregor, Aria Olumi, Kimryn Rathmell, Keyan Salari and Vincent Xu